Page last updated: 2024-11-07

idoxuridine and Cancer of Gastrointestinal Tract

idoxuridine has been researched along with Cancer of Gastrointestinal Tract in 4 studies

Research Excerpts

ExcerptRelevanceReference
"One patient with recurrent ovarian cancer who received 16 courses of therapy experienced complete resolution of her ascites, near normalization of CA-125 levels, and improved quality of life; two patients with high-risk tumors receiving "adjuvant" therapy are disease-free at 3 and 6 years after treatment; other patients experienced transient clearing of ascites."2.69Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. ( Akman, S; Carroll, M; Chow, W; Coluzzi, P; Doroshow, JH; Hamasaki, V; Klevecz, R; Leong, L; Longmate, J; Margolin, K; McGonigle, K; Morgan, RJ; Newman, EM; Paz, B; Raschko, J; Shibata, S; Somlo, G; Tetef, M; Vasilev, S; Wagman, L; Yen, Y, 1998)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinsella, T1
Safran, H1
Wiersma, S1
DiPetrillo, T1
Schumacher, A1
Rosati, K1
Vatkevich, J1
Anderson, LW1
Hill, KD1
Kunos, C1
Collins, JM1
Morgan, RJ1
Newman, EM1
Doroshow, JH1
McGonigle, K1
Margolin, K1
Raschko, J1
Chow, W1
Somlo, G1
Leong, L1
Tetef, M1
Shibata, S1
Hamasaki, V1
Carroll, M1
Vasilev, S1
Akman, S1
Coluzzi, P1
Wagman, L1
Longmate, J1
Paz, B1
Yen, Y1
Klevecz, R1
McGinn, CJ1
Kunugi, KA1
Tutsch, KD1
Feierabend, C1
Alberti, D1
Lindstrom, MJ1
Wilding, G1
Arzoomanian, RZ1
Kinsella, TJ1
Raza, A1
Miller, MA1
Mazewski, C1
Sheikh, Y1
Lampkin, B1
Sawaya, R1
Crone, K1
Berger, T1
Reising, J1
Gray, J1

Trials

3 trials available for idoxuridine and Cancer of Gastrointestinal Tract

ArticleYear
Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 10-15, Volume: 25, Issue:20

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Dose Fractionation, Radiati

2019
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Cancer research, 1998, Jul-01, Volume: 58, Issue:13

    Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; CA-125 Antigen; DNA, Neoplasm; Drug Adminis

1998
Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:8

    Topics: Adult; Aged; Female; Gastrointestinal Neoplasms; Humans; Idoxuridine; Leucovorin; Male; Middle Aged;

1996

Other Studies

1 other study available for idoxuridine and Cancer of Gastrointestinal Tract

ArticleYear
Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine.
    Cell proliferation, 1991, Volume: 24, Issue:2

    Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Nucleus; DNA Replication; Gastroint

1991